NervGen Pharma Corp. Financial Flexibility Index
NervGen Pharma Corp. financial flexibility index. NervGen Pharma Corp. (NGEN) has a Financial Flexibility Index of -0.08x as of June 2026. Free cash flow of $-5.81 Million (operating CF $-5.81 Million minus capex $0.00) represents 0% of total liabilities ($73.03 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of NervGen Pharma Corp. (2018–2025)
Financial flexibility index of NervGen Pharma Corp. from 2018 to 2025. Historical Financial Flexibility Index trend for NervGen Pharma Corp. across 8 annual periods. Explore NGEN debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
NervGen Pharma Corp. Financial Flexibility Index by Year (2018–2025)
NervGen Pharma Corp. financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for NervGen Pharma Corp.. For the full cash flow conversion analysis, see NervGen Pharma Corp. cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.99x | $-19.50 Million | $-19.50 Million | $19.73 Million | ▲ +0.8% |
| 2024 | -1.00x | $-16.83 Million | $-16.83 Million | $16.90 Million | ▼ -34.5% |
| 2023 | -0.74x | $-11.29 Million | $-11.30 Million | $15.25 Million | ▲ +56.6% |
| 2022 | -1.71x | $-17.61 Million | $-17.63 Million | $10.32 Million | ▲ +77.8% |
| 2021 | -7.67x | $-8.33 Million | $-8.33 Million | $1.09 Million | ▲ +8.2% |
| 2020 | -8.35x | $-6.32 Million | $-6.32 Million | $756.78K | ▲ +4.7% |
| 2019 | -8.76x | $-8.31 Million | $-8.31 Million | $949.14K | ▼ -391.1% |
| 2018 | -1.78x | $-1.04 Million | $-1.04 Million | $581.26K | — |